20 Hrs
Source:
أنا حوا
Source: أنا حوا
20 Hrsأنا حوا
Source: أنا حوا
20 HrsReady to play
Ready to play
A preliminary study succeeded in using genetically modified cells to treat advanced ovarian cancer, where cells produced through genetic engineering were implanted into the abdominal cavity near the tumors. These cells release "Interleukin-2," which activates the immune system to attack the cancer, while reducing the side effects associated with direct injection of the substance. In a trial involving 14 patients resistant to chemotherapy, the results showed disease stabilization and an increase in immune cells capable of attacking the cancer, offering hope that this technique could improve ovarian cancer treatments in the future, although it is still in the experimental stage.
Notice: This Is an AI-Generated Summary
Comments (0)